NI-28 ANALYSIS OF BEVACIZUMAB RESPONSE TO DISTINGUISH BETWEEN TUMOR RECURRENCE AND CEREBRAL RADIATION NECROSIS

OBJECTIVE: Recurrent malignant gliomas are the disease stage difficult to control progressive tumor (PT). Most of them has a treatment history of radiotherapy and there are more than a few lesion with a component of cerebral radiation necrosis (RN) (Fujimoto, 2013). Bevacizumab (BEV) is a possible t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fujimoto, Koichi, Arakawa, Yoshiki, Murata, Daiki, Fukui, Nobuyuki, Kunieda, Takeharu, Takagi, Yasushi, Miyamoto, Susumu
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218353/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou264.27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares